Search filters

List of works by Francisco Téllez

A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.

scientific article published on 24 September 2013

A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)

scientific article published on 10 July 2019

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis

scientific article published on 19 February 2013

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.

scientific article published on September 2017

Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain.

scientific article published on 19 October 2015

Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes

scientific article published on 01 October 2019

DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients

scientific article published on 01 August 2019

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain

scientific article

Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients

article

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens

scientific article

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.

scientific article

Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals.

scientific article

Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR

scientific article published on 29 August 2019

Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users

article

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

article

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

scientific article published on 18 November 2020

Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.

scientific article published on 24 January 2017

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection

scientific article published on 21 June 2019

HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals

scientific article published on 01 June 2019

HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.

scientific article published on May 2017

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study

scientific article

Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study

scientific article

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients.

scientific article published on August 2012

Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.

scientific article published on 23 July 2015

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

article

High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world

scientific article published on 04 July 2019

Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks

scientific article published on 14 May 2019

Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals

scientific article published on September 2015

Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.

scientific article published on 28 January 2018

Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

scientific article published on 27 October 2016

Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain

scientific article published on 26 December 2020

Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain

article

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain

scientific article published on 05 September 2012

Integrase strand-transfer inhibitors for treatment of early HIV infection: A case series

scientific article published on 01 August 2019

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort

scientific article published on 5 February 2016

Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis.

scientific article published in August 2009

Liver stiffness at the time of sustained virological response predicts the clinical outcome in HIV/HCV-coinfected patients with advanced fibrosis treated with direct-acting antivirals

scientific article published on 22 November 2019

Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis.

scientific article published on 9 March 2012

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.

scientific article published in October 2013

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis

scientific article published on 6 June 2012

Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis

scientific article

Liver stiffness-based strategies predict absence of variceal bleeding in cirrhotic HCV-infected patients with and without HIV-coinfection after sustained virological response

scientific article published on 19 November 2020

Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C

article

Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors

scientific article published on 01 December 2018

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection

scientific article published on 7 December 2015

Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients

article

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.

scientific article published on 20 March 2015

Monotherapy with darunavir/ritonavir is effective and safe in clinical practice

scientific article published on 2 November 2014

News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference

scientific article

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014

scientific article

Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients

scientific article published on 22 April 2019

Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice

scientific article published on 15 February 2018

Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease

scientific article published on 09 December 2019

Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort

scientific article published on 30 August 2019

Proceedings of The 8th Romanian National HIV/AIDS Congress and The 3rd Central European HIV Forum : Sibiu, Romania. 5-7 May 2016

article

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.

scientific article published on 7 December 2015

Progression to Hepatitis C virus microelimination in people living with HIV in Spain

scientific article published on 30 October 2020

Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients.

scientific article

Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study.

scientific article

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis

scientific article published in PLoS ONE

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

scientific article published on 08 March 2019

Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis

scientific article published on 5 September 2012

Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.

scientific article published on 14 August 2013

Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C

scientific article published on 10 October 2012

Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection

scientific article published on 27 September 2018

Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.

scientific article

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.

scientific article

The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy

scientific article published on 11 April 2019

Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals

scientific article published on 10 January 2020

Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

scientific article published on 27 January 2017